Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng-Ming Hsu

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Journal of Gastroenterology and Hepatology|February 17, 2015
Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinomaChiao-Ling Tsai, Feng-Ming Hsu, Kai-Yuan Tzen, et al.
International Journal of Radiation Biology|June 24, 2026
Cardiac substructure dose and the risk of arrhythmia after curative radiotherapy for thymic tumorsTing-Fong Liu, Feng-Ming Hsu, Wen-Chi Yang, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 18, 2013
Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: a planning and feasibility studyYi-Chun Tsai, Chiao-Ling Tsai, Feng-Ming Hsu, et al.
Journal of Clinical and Translational Hepatology|March 27, 2023
Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell CytotoxicityChiao-Ling Tsai, Po-Sheng Yang, Feng-Ming Hsu, et al.
Scientific Reports|May 19, 2015
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant ChemoradiationFeng-Ming Hsu, Jason Chia-Hsien Cheng, Yih-Leong Chang, et al.
Digestive Surgery|July 5, 2017
Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?Pei-Ming Huang, Feng-Ming Hsu, Chia-Chi Lin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 17, 2009
Using cone-beam computed tomography to evaluate the impact of bladder filling status on target position in prostate radiotherapyChiao-Ling Tsai, Jian-Kuen Wu, Chun-Wei Wang, et al.
Case Reports in Oncology|October 11, 2016
Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung CancerShao-Lun Lu, Feng-Ming Hsu, Kuan-Yu Chen, et al.
Nanoscale Research Letters|January 24, 2022
Kinetics and Mechanism of In Situ Metallization of Bulk DNA FilmsZi-Hao Shi, Feng-Ming Hsu, Bradley W Mansel, et al.
Radiation Oncology (London, England)|March 8, 2020
Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cellsYun Tien, Chiao-Ling Tsai, Wei-Hsien Hou, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Journal of Gastroenterology and Hepatology|February 17, 2015
Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinomaChiao-Ling Tsai, Feng-Ming Hsu, Kai-Yuan Tzen, et al.
International Journal of Radiation Biology|June 24, 2026
Cardiac substructure dose and the risk of arrhythmia after curative radiotherapy for thymic tumorsTing-Fong Liu, Feng-Ming Hsu, Wen-Chi Yang, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 18, 2013
Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: a planning and feasibility studyYi-Chun Tsai, Chiao-Ling Tsai, Feng-Ming Hsu, et al.
Journal of Clinical and Translational Hepatology|March 27, 2023
Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell CytotoxicityChiao-Ling Tsai, Po-Sheng Yang, Feng-Ming Hsu, et al.
Scientific Reports|May 19, 2015
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant ChemoradiationFeng-Ming Hsu, Jason Chia-Hsien Cheng, Yih-Leong Chang, et al.
Digestive Surgery|July 5, 2017
Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?Pei-Ming Huang, Feng-Ming Hsu, Chia-Chi Lin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 17, 2009
Using cone-beam computed tomography to evaluate the impact of bladder filling status on target position in prostate radiotherapyChiao-Ling Tsai, Jian-Kuen Wu, Chun-Wei Wang, et al.
Case Reports in Oncology|October 11, 2016
Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung CancerShao-Lun Lu, Feng-Ming Hsu, Kuan-Yu Chen, et al.
Nanoscale Research Letters|January 24, 2022
Kinetics and Mechanism of In Situ Metallization of Bulk DNA FilmsZi-Hao Shi, Feng-Ming Hsu, Bradley W Mansel, et al.
Radiation Oncology (London, England)|March 8, 2020
Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cellsYun Tien, Chiao-Ling Tsai, Wei-Hsien Hou, et al.
Pageof 8